Seonhwa Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Seonhwa Lee has a total of 98 co-authors. Here are the top co-authors by number of shared publications:
- Chi Young Shim
Severance Cardiovascular Hospital, Yonsei University College of Medicine
9 shared publications - In-Cheol Kim
Division of Cardiology, Keimyung University Dongsan Medical Center, Daegu, Korea
8 shared publications - Iksung Cho
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea
7 shared publications - Geu-Ru Hong
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea
6 shared publications - Hyungseop Kim
Division of Cardiology, Keimyung University Dongsan Medical Center, Daegu, Korea
5 shared publications - Jiwon Seo
Division of Cardiology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine , Seoul
5 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (5) , 404-418
Temporal Trend of Cardiovascular Disease Burden Among Cancer Patients Between 2005 and 2022: Nationwide Population-Based Cohort Study in South Korea
Cho I, et al. Korean Circ J. 2026 ;56:e53. https://doi.org/10.4070/kcj.2025.0171
- 1 January 2026
- Published by XMLink in Korean Circulation Journal
- Vol. 56 (5) , 404-418
Open AccessTemporal Trend of Cardiovascular Disease Burden Among Cancer Patients Between 2005 and 2022: Nationwide Population-Based Cohort Study in South Korea
Cho I, et al. Korean Circ J. 2026 ;56:e53. https://doi.org/10.4070/kcj.2025.0171
- Open Access
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (2) , 87-95
Prognosis of Infective Endocarditis According to Clinical Characteristics, Economic Status, and Center Experience
Kim WD, et al. Yonsei Med J. 2025 Dec;66:e114. https://doi.org/10.3349/ymj.2025.0122
- 1 January 2026
- Published by XMLink in Yonsei Medical Journal
- Vol. 67 (2) , 87-95
Open AccessPrognosis of Infective Endocarditis According to Clinical Characteristics, Economic Status, and Center Experience
Kim WD, et al. Yonsei Med J. 2025 Dec;66:e114. https://doi.org/10.3349/ymj.2025.0122
- 1 September 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (9) , e018124
Long-Term Follow-Up in Severe Mitral Stenosis With Low Transmitral Diastolic Pressure Gradient: From MASTER Registry
BACKGROUND: Long-term follow-up studies in severe mitral stenosis (MS) with low transmitral mean diastolic pressure gradient (MDPG) are not available. We evaluated the prognostic implications of severe MS with low MDPG in our MASTER (Multicenter Mitral Stenosis with Rheumatic Etiology) registry. METHODS: We included patients with severe rheumatic MS (mitral valve area ≤1.5 cm 2 ) from the long-term MASTER registry. Patients were categorized into high (≥5 mm Hg) or low (P =0.004), and low MDPG was independently associated with poor outcome (hazard ratio, 1.42 [95% CI, 1.02–1.97]; P =0.038) in the multivariable model. In the subgroup analysis of patients with low MDPG, decreased left atrial reservoir strain was independently associated with poor outcome (hazard ratio, 3.22 [95% CI, 1.25–8.31]; P =0.016). CONCLUSIONS: Patients with severe MS and low MDPG carried a greater risk of adverse events than those with high MDPG and had less frequent and delayed mitral valve intervention. Also, it is not necessarily indicative of milder hemodynamic encumbrance. Left atrial reservoir strain could help identify a subgroup associated with poor prognosis in patients with low MDPG.
- 1 September 2025
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Imaging
- Vol. 18 (9) , e018124
Long-Term Follow-Up in Severe Mitral Stenosis With Low Transmitral Diastolic Pressure Gradient: From MASTER Registry
BACKGROUND: Long-term follow-up studies in severe mitral stenosis (MS) with low transmitral mean diastolic pressure gradient (MDPG) are not available. We evaluated the prognostic implications of severe MS with low MDPG in our MASTER (Multicenter Mitral Stenosis with Rheumatic Etiology) registry. METHODS: We included patients with severe rheumatic MS (mitral valve area ≤1.5 cm 2 ) from the long-term MASTER registry. Patients were categorized into high (≥5 mm Hg) or low (P =0.004), and low MDPG was independently associated with poor outcome (hazard ratio, 1.42 [95% CI, 1.02–1.97]; P =0.038) in the multivariable model. In the subgroup analysis of patients with low MDPG, decreased left atrial reservoir strain was independently associated with poor outcome (hazard ratio, 3.22 [95% CI, 1.25–8.31]; P =0.016). CONCLUSIONS: Patients with severe MS and low MDPG carried a greater risk of adverse events than those with high MDPG and had less frequent and delayed mitral valve intervention. Also, it is not necessarily indicative of milder hemodynamic encumbrance. Left atrial reservoir strain could help identify a subgroup associated with poor prognosis in patients with low MDPG.
- Open Access
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (10) , 938-951
Association Between Vasoactive Inotropic Score and Clinical Outcomes in Patients With Fulminant Myocarditis
Hong D, et al. Korean Circ J. 2025 May;55:e87. https://doi.org/10.4070/kcj.2024.0445
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (10) , 938-951
Open AccessAssociation Between Vasoactive Inotropic Score and Clinical Outcomes in Patients With Fulminant Myocarditis
Hong D, et al. Korean Circ J. 2025 May;55:e87. https://doi.org/10.4070/kcj.2024.0445
- Open Access
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (5) , 396-407
Comparison of Thick Biolimus A9-Eluting Stent and Thin Zotarolimus-Eluting Stent in Multi-Vessel Percutaneous Coronary Intervention
Lee CH, et al. Korean Circ J. 2025 Feb;55:e40. https://doi.org/10.4070/kcj.2024.0101
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (5) , 396-407
Open AccessComparison of Thick Biolimus A9-Eluting Stent and Thin Zotarolimus-Eluting Stent in Multi-Vessel Percutaneous Coronary Intervention
Lee CH, et al. Korean Circ J. 2025 Feb;55:e40. https://doi.org/10.4070/kcj.2024.0101
- Open Access
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (5) , 410-422
Clinical Characteristics and Outcomes of Acute Myocarditis: An Analysis of Korean Multicenter Registry
Hyun J, et al. Korean Circ J. 2024 Dec;55:e29. https://doi.org/10.4070/kcj.2024.0229
- 1 January 2025
- Published by XMLink in Korean Circulation Journal
- Vol. 55 (5) , 410-422
Open AccessClinical Characteristics and Outcomes of Acute Myocarditis: An Analysis of Korean Multicenter Registry
Hyun J, et al. Korean Circ J. 2024 Dec;55:e29. https://doi.org/10.4070/kcj.2024.0229
- 31 December 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (4) , 705-711
Selecting the optimal candidates for percutaneous mitral valvuloplasty using multi-modality imaging
Aims: This study compared echocardiography (echo) and cardiac computed tomography (CT) in measuring the Wilkins score and evaluated the potential added benefit of CT in predicting immediate percutaneous mitral valvuloplasty (PMV) outcomes in rheumatic mitral stenosis (MS) patients deemed eligible for PMV by echo. Methods and results: From a multicentre registry of 3,140 patients with at least moderate MS, we included 96 patients (age 56.4 ± 11.5 years, 81% female) eligible for PMV based on echo Wilkins score (≤9) who underwent PMV and had measurable CT and echo images. We compared Wilkins scores from both modalities and analysed their relationship with unsuccessful procedural outcomes, defined as sub-optimal post-procedural mitral valve area (<1.5 cm2) or newly developed mitral regurgitation Grade ≥III. The mean CT score was higher than the echo score (8.0 ± 2.4 vs. 7.3 ± 1.2 points, P = 0.005). Procedural success was achieved in 65 (67.7%) patients. Unsuccessful results occurred in 31 patients, primarily in intermediate echo score (7–9 points) group. Among patients with intermediate echo scores, 90% had high CT scores (≥9), which were associated with significantly higher rates of unsuccessful PMV compared with lower CT scores (61.1 vs. 18.9%, P < 0.001). Conclusion: CT-derived Wilkins scores were higher than echo-derived scores, with the most significant discrepancy in the intermediate echo score group. CT identified a subgroup of patients at higher risk for unsuccessful PMV among those with intermediate echo-based feasibility. Patients with intermediate echo-based PMV feasibility may benefit from CT-based reclassification, potentially improving patient selection and procedural outcomes.
- 31 December 2024
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 26 (4) , 705-711
Selecting the optimal candidates for percutaneous mitral valvuloplasty using multi-modality imaging
Aims: This study compared echocardiography (echo) and cardiac computed tomography (CT) in measuring the Wilkins score and evaluated the potential added benefit of CT in predicting immediate percutaneous mitral valvuloplasty (PMV) outcomes in rheumatic mitral stenosis (MS) patients deemed eligible for PMV by echo. Methods and results: From a multicentre registry of 3,140 patients with at least moderate MS, we included 96 patients (age 56.4 ± 11.5 years, 81% female) eligible for PMV based on echo Wilkins score (≤9) who underwent PMV and had measurable CT and echo images. We compared Wilkins scores from both modalities and analysed their relationship with unsuccessful procedural outcomes, defined as sub-optimal post-procedural mitral valve area (<1.5 cm2) or newly developed mitral regurgitation Grade ≥III. The mean CT score was higher than the echo score (8.0 ± 2.4 vs. 7.3 ± 1.2 points, P = 0.005). Procedural success was achieved in 65 (67.7%) patients. Unsuccessful results occurred in 31 patients, primarily in intermediate echo score (7–9 points) group. Among patients with intermediate echo scores, 90% had high CT scores (≥9), which were associated with significantly higher rates of unsuccessful PMV compared with lower CT scores (61.1 vs. 18.9%, P < 0.001). Conclusion: CT-derived Wilkins scores were higher than echo-derived scores, with the most significant discrepancy in the intermediate echo score group. CT identified a subgroup of patients at higher risk for unsuccessful PMV among those with intermediate echo-based feasibility. Patients with intermediate echo-based PMV feasibility may benefit from CT-based reclassification, potentially improving patient selection and procedural outcomes.
- Open Access
- 29 April 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e52075
Effectiveness of a Smartphone App–Based Intervention With Bluetooth-Connected Monitoring Devices and a Feedback System in Heart Failure (SMART-HF Trial): Randomized Controlled Trial
Background: Current heart failure (HF) guidelines recommend a multidisciplinary approach, discharge education, and self-management for HF. However, the recommendations are challenging to implement in real-world clinical settings. Objective: We developed a mobile health (mHealth) platform for HF self-care to evaluate whether a smartphone app–based intervention with Bluetooth-connected monitoring devices and a feedback system can help improve HF symptoms. Methods: In this prospective, randomized, multicenter study, we enrolled patients 20 years of age and older, hospitalized for acute HF, and who could use a smartphone from 7 tertiary hospitals in South Korea. In the intervention group (n=39), the apps were automatically paired with Bluetooth-connected monitoring devices. The patients could enter information on vital signs, HF symptoms, diet, medications, and exercise regimen into the app daily and receive feedback or alerts on their input. In the control group (n=38), patients could only enter their blood pressure, heart rate, and weight using conventional, non-Bluetooth devices and could not receive any feedback or alerts from the app. The primary end point was the change in dyspnea symptom scores from baseline to 4 weeks, assessed using a questionnaire. Results: At 4 weeks, the change in dyspnea symptom score from baseline was significantly greater in the intervention group than in the control group (mean –1.3, SD 2.1 vs mean –0.3, SD 2.3; P=.048). A significant reduction was found in body water composition from baseline to the final measurement in the intervention group (baseline level mean 7.4, SD 2.5 vs final level mean 6.6, SD 2.5; P=.003). App adherence, which was assessed based on log-in or the percentage of days when symptoms were first observed, was higher in the intervention group than in the control group. Composite end points, including death, rehospitalization, and urgent HF visits, were not significantly different between the 2 groups. Conclusions: The mobile-based health platform with Bluetooth-connected monitoring devices and a feedback system demonstrated improvement in dyspnea symptoms in patients with HF. This study provides evidence and rationale for implementing mobile app–based self-care strategies and feedback for patients with HF. Trial Registration: ClinicalTrials.gov NCT05668000; https://clinicaltrials.gov/study/NCT05668000
- 29 April 2024
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 26, e52075
Open AccessEffectiveness of a Smartphone App–Based Intervention With Bluetooth-Connected Monitoring Devices and a Feedback System in Heart Failure (SMART-HF Trial): Randomized Controlled Trial
Background: Current heart failure (HF) guidelines recommend a multidisciplinary approach, discharge education, and self-management for HF. However, the recommendations are challenging to implement in real-world clinical settings. Objective: We developed a mobile health (mHealth) platform for HF self-care to evaluate whether a smartphone app–based intervention with Bluetooth-connected monitoring devices and a feedback system can help improve HF symptoms. Methods: In this prospective, randomized, multicenter study, we enrolled patients 20 years of age and older, hospitalized for acute HF, and who could use a smartphone from 7 tertiary hospitals in South Korea. In the intervention group (n=39), the apps were automatically paired with Bluetooth-connected monitoring devices. The patients could enter information on vital signs, HF symptoms, diet, medications, and exercise regimen into the app daily and receive feedback or alerts on their input. In the control group (n=38), patients could only enter their blood pressure, heart rate, and weight using conventional, non-Bluetooth devices and could not receive any feedback or alerts from the app. The primary end point was the change in dyspnea symptom scores from baseline to 4 weeks, assessed using a questionnaire. Results: At 4 weeks, the change in dyspnea symptom score from baseline was significantly greater in the intervention group than in the control group (mean –1.3, SD 2.1 vs mean –0.3, SD 2.3; P=.048). A significant reduction was found in body water composition from baseline to the final measurement in the intervention group (baseline level mean 7.4, SD 2.5 vs final level mean 6.6, SD 2.5; P=.003). App adherence, which was assessed based on log-in or the percentage of days when symptoms were first observed, was higher in the intervention group than in the control group. Composite end points, including death, rehospitalization, and urgent HF visits, were not significantly different between the 2 groups. Conclusions: The mobile-based health platform with Bluetooth-connected monitoring devices and a feedback system demonstrated improvement in dyspnea symptoms in patients with HF. This study provides evidence and rationale for implementing mobile app–based self-care strategies and feedback for patients with HF. Trial Registration: ClinicalTrials.gov NCT05668000; https://clinicaltrials.gov/study/NCT05668000
- Open Access
- 1 January 2024
- Published by XMLink in Korean Circulation Journal
- Vol. 54 (8) , 468-481
Proteome-wide Characterization and Pathophysiology Correlation in Non-ischemic Cardiomyopathies
Lee S, et al. Korean Circ J. 2024 Jun;54:e66. https://doi.org/10.4070/kcj.2024.0033
- 1 January 2024
- Published by XMLink in Korean Circulation Journal
- Vol. 54 (8) , 468-481
Open AccessProteome-wide Characterization and Pathophysiology Correlation in Non-ischemic Cardiomyopathies
Lee S, et al. Korean Circ J. 2024 Jun;54:e66. https://doi.org/10.4070/kcj.2024.0033
- Open Access
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (17) , e152
Shifts in Clinical Characteristics, Treatment, and Outcome for Rheumatic Mitral Stenosis: Insights From a 20-Year Multicentre Registry Study in Korea
Lee HJ, et al. J Korean Med Sci. 2024 Apr;39(17):e152. https://doi.org/10.3346/jkms.2024.39.e152
- 1 January 2024
- Published by XMLink in Journal of Korean Medical Science
- Vol. 39 (17) , e152
Open AccessShifts in Clinical Characteristics, Treatment, and Outcome for Rheumatic Mitral Stenosis: Insights From a 20-Year Multicentre Registry Study in Korea
Lee HJ, et al. J Korean Med Sci. 2024 Apr;39(17):e152. https://doi.org/10.3346/jkms.2024.39.e152